Neisseria meningitidis serogroup b nhba fusion protein antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Neisseria meningitidis serogroup b nhba fusion protein antigen
Accession Number
DB10783
Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Other vaccines
Description
Not Available
Synonyms
  • Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
BexseroNeisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5mL) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5mL) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5mL) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5mL)SuspensionIntramuscularGlaxosmithkline Inc2014-02-26Not applicableCanada
BexseroNeisseria meningitidis serogroup b nhba fusion protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 ug/0.5mL) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup b nada protein antigen (50 ug/0.5mL)Injection, suspensionIntramuscularGlaxoSmithKline Biologicals SA2016-12-01Not applicableUs
BexseroNeisseria meningitidis serogroup b nhba fusion protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 ug/0.5mL) + Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup b nada protein antigen (50 ug/0.5mL)Injection, suspensionIntramuscularNovartis Vaccines And Diagnostics Srl2015-01-232017-10-31Us
Categories
Not Available
UNII
28E911Y7AE
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedPreventionRespiratory Synctial Virus Infections1
1RecruitingPreventionInfections, Respiratory Syncytial Virus1
2Active Not RecruitingPreventionInfectious Diseases1
2CompletedOtherMeningococcal Disease / Meningococcal Infections1
2CompletedPreventionMeningococcal Meningitis1
3CompletedPreventionMeningoccocal Disease / Meningococcal Meningitis1
3CompletedPreventionMeningococcal Disease1
3CompletedPreventionMeningococcal Disease / Meningococcal Infections1
3RecruitingPreventionMeningococcal Infection (Healthy Volunteers)1
3RecruitingPreventionMeningococcal Infections1
4Active Not RecruitingHealth Services ResearchHealthy Volunteers1
4Active Not RecruitingPreventionInfants, Premature / Meningococcal Disease / Vaccination1
4CompletedBasic ScienceMeningitis1
4CompletedOtherMeningococcal Serogroup B1
4CompletedPreventionMeningococcal Disease1
4RecruitingOtherHuman Immunodeficiency Virus (HIV) / Human Immunodeficiency Virus (HIV) Infections / Meningococcal Meningitis1
4RecruitingOtherMeningococcal Meningitis1
4RecruitingTreatmentNeisseria Gonorrhoeae Infection1
Not AvailableActive Not RecruitingNot AvailableMeningococcal Infections1
Not AvailableActive Not RecruitingBasic ScienceFactor H-binding Protein, Neisseria Meningitidi / Meningococcal Infections / Meningococcal Vaccines / Neisseria Meningitidis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, suspensionIntramuscular
SuspensionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on December 01, 2015 13:04 / Updated on September 02, 2019 19:17